SKANZ Stock Overview
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SKAN Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 79.10 |
| 52 Week High | CHF 86.40 |
| 52 Week Low | CHF 69.40 |
| Beta | 0.98 |
| 1 Month Change | 2.86% |
| 3 Month Change | -1.13% |
| 1 Year Change | 4.77% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 50.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| SKANZ | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | -0.6% | 1.1% | 2.0% |
| 1Y | 4.8% | -10.2% | 10.8% |
Return vs Industry: SKANZ exceeded the UK Life Sciences industry which returned -10.2% over the past year.
Return vs Market: SKANZ underperformed the UK Market which returned 10.8% over the past year.
Price Volatility
| SKANZ volatility | |
|---|---|
| SKANZ Average Weekly Movement | 3.6% |
| Life Sciences Industry Average Movement | 8.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: SKANZ has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: SKANZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,419 | GL Huber | skan.com/de/home/ |
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.
SKAN Group AG Fundamentals Summary
| SKANZ fundamental statistics | |
|---|---|
| Market cap | CHF 1.77b |
| Earnings (TTM) | CHF 32.24m |
| Revenue (TTM) | CHF 344.01m |
55.0x
P/E Ratio5.2x
P/S RatioIs SKANZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKANZ income statement (TTM) | |
|---|---|
| Revenue | CHF 344.01m |
| Cost of Revenue | CHF 95.69m |
| Gross Profit | CHF 248.32m |
| Other Expenses | CHF 216.08m |
| Earnings | CHF 32.24m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 25, 2025
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 72.18% |
| Net Profit Margin | 9.37% |
| Debt/Equity Ratio | 3.5% |
How did SKANZ perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield24%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 01:15 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SKAN Group AG is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Leonildo Delgado | Baader Helvea Equity Research |
| Samuel England | Berenberg |